CPWY Stock 0.033   +0.006 +22.20% Updated: 03-03-2019

New Post Public Reply Private Reply Replies (0) Message Board
stockcharts
104
CPWY Stock 0.033   +0.006 +22.20% Updated: 03-03-2019 $CPWY
Last Trade: 3/1/2019 1:47:00 PM

Last 0.033   +0.006 +22.20%
Open 0.029
Previous Close 0.027
Day High / Low 0.035 / 0.023
Year High / Low 2.000 / 0.006
Volume 4,907,848
Projected Volume 4907848 (4752%)
# of Trades / Projected 304 / 304
Dividend / Yield - / -
Abnormal Activity NONE
Abnormal Volume NO
Gap NONE
Candle NEUTRAL
Volatility Today LOW
Volatility Yesterday LOW
Price Relativity
From 40 Day High 42%
From 80 Day High 40%
From 150 Day High 35%
From 40 Day Low 109%
From 80 Day Low 115%
From 150 Day Low 152%
Pivot Analysis
Price Pivot $ 0.000
Day Resistance 1 $ 0.000
Day Support 1 $ 0.000
Day Resistance 2 $ 0.000
Day Support 2 $ 0.000
Consolidations
Short Term YES
Medium Term YES
Long Term YES
Volume Indicators
20 Day Avg Vol 103,285
Today / 20 Day Avg Vol BELOW
150 Day Avg Vol 89,631
Today / 150 Day Avg Vol BELOW
Abnormal Volume NO
William Volume Accumulation bullish
Volume Price Trend bullish
Momentum Indicators
10 Day Trend bearish
40 Day Trend bearish
100 Day Trend bullish
Stochastics neutral
RSI bearish
MACD bearish
Moving Average Indictors
15 Day Trend bearish
45 Day Trend bearish
100 Day Trend bullish
Mid Term Moving Average Crossover NONE
Long Term Moving Average Crossover BELOW
Volatility Indicators
Abnormal Activity Today? NONE
Volatility Index Today LOW
Volatility Index Yesterday LOW
10 Day Volatility DECREASING
20 Day Volatility DECREASING
40 Day Volatility DECREASING

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Frontera Energy Set to Release Quarterly Financial Results Soon

Updated Category News Views 253

Frontera Energy Announces First Quarter Financial Results Frontera Energy Corporation (TSX: FEC) has exciting news for its shareholders and interested investors. The Company is set to unveil its financial and operational results for the first quarter, wrapping up on March 31, 2025. This significant announcement will occur after the market closes on a forthcoming Thursday...

Continue Reading
The Rising Value of Contrast Media Injectors in Healthcare

Updated Category News Views 133

Exploring the Global Market for Contrast Media Injectors The global market for contrast media injectors is on the verge of substantial growth, with projections indicating it will reach $2.1 billion in the coming years. This anticipated growth, at a compound annual growth rate (CAGR) of 7.8% from 2025 through 2033, is primarily driven by ongoing advances in technology and...

Continue Reading
Beth Wozniak Sells nVent Electric Shares Worth $884K

Updated Category News Views 158

Beth Wozniak's Recent Stock Sale at nVent Electric Beth Wozniak, Chair & CEO of nVent Electric (NYSE:NVT), executed a significant insider sale recently, as revealed in a new SEC filing. This transaction involved the offloading of 7,597 shares, with a total value of approximately $884,822. Such movements in stock ownership often pique the interest of investors, prompting...

Continue Reading
Electoral Impact of Rising Home Prices on Kamala Harris' Campaign

Updated Category News Views 211

The Impact of Home Prices on the Upcoming Election As we approach the presidential election, the role that home prices play in shaping voter sentiments is becoming increasingly evident. Recent research has shown that fluctuations in the housing market can significantly affect how voters make their choices, particularly in crucial battleground states. Current Trends in...

Continue Reading
Iambic Therapeutics Welcomes Michael Secora as CFO and CDO

Updated Category News Views 134

Iambic Therapeutics Welcomes Michael Secora as CFO and CDO Iambic Therapeutics has announced an important leadership change, appointing Michael Secora, Ph.D., as its Chief Corporate Development Officer and Chief Financial Officer. This decision comes as Iambic continues its commitment to pioneering novel medicines through its innovative AI-driven drug discovery platform....

Continue Reading